drugset / Trial / NCT00868010

Enhancing Rehabilitation After Stroke

NCT00868010

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a 12-week, randomized, placebo controlled study to determine if donepezil (Aricept) treatment during rehabilitation after stroke improves functional recovery.

Timeline

Start
2009-03
Primary completion
2013-08
Completion
2013-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 5 mg
Subject Donepezil Small molecule 10 mg

Indications